Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
LakeShore Biopharma Co., Ltd - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
LSB
Nasdaq
2834
www.ysbiopharm.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for LakeShore Biopharma Co., Ltd
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
- Dec 19th, 2024 2:05 pm
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China
- Dec 13th, 2024 12:57 am
LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan
- Nov 7th, 2024 1:00 pm
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Oct 29th, 2024 12:30 pm
LakeShore Biopharma Advances with Rabies Vaccine Trial
- Oct 26th, 2024 1:00 pm
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
- Oct 25th, 2024 12:30 pm
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
- Oct 8th, 2024 12:30 pm
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
- Sep 27th, 2024 11:00 am
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
- Sep 10th, 2024 12:00 pm
LakeShore Biopharma Announces Leadership Transitions
- Sep 4th, 2024 12:00 pm
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
- Aug 15th, 2024 12:30 pm
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
- Jul 5th, 2024 11:00 am
LakeShore Biopharma Insider Ups Holding By 3,083% During Year
- Jun 30th, 2024 2:22 pm
LakeShore Biopharma Co., Ltd (NASDAQ:LSB): When Will It Breakeven?
- Jun 3rd, 2024 11:38 am
Scroll